Bacillus Calmette-Guerin (BCG) unresponsive non-muscle-invasive bladder cancer: are the subgroups equal?

被引:1
|
作者
Tan, Wei Shen [1 ]
Grajales, Valentina [1 ]
Bree, Kelly [1 ]
Li, Roger [2 ]
Nogueras-Gonzalez, Graciela M. [3 ]
Navai, Neema [1 ]
Dinney, Colin [1 ]
Kamat, Ashish M. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Urol, Tampa, FL USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX USA
关键词
bacillus Calmette-Guerin; bladder cancer; bladder-sparing treatment; refractory; relapsing; outcomes;
D O I
10.1111/bju.16087
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:384 / 386
页数:3
相关论文
共 50 条
  • [41] Bacillus Calmette-Guerin Failure in Non-muscle-invasive Bladder Cancer: One Size Does Not Fit All
    McKiernan, James
    EUROPEAN UROLOGY, 2016, 70 (05) : 786 - 787
  • [42] ROLE OF ORAL PENTOSAN POLYSULFATE IN BACILLUS CALMETTE-GUERIN THERAPY IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER
    Hyeon, Yu Seong
    Seok, Chung Ho
    Chang, Hwang Eu
    Sun-Ouck, Kim
    Jin, Oh Kyung
    Il, Jung Seung
    Won, Kang Taek
    Dongdeuk, Kwon
    Kwangsung, Park
    JOURNAL OF UROLOGY, 2022, 207 (05): : E935 - E935
  • [43] Role of oral pentosan polysulfate in Bacillus Calmette-Guerin therapy in patients with non-muscle-invasive bladder cancer
    Lee, Ho Yeon
    Jung, Seung Il
    Lim, Do Gyeong
    Chung, Ho Seok
    Hwang, Eu Chang
    Kwon, Dong Deuk
    INVESTIGATIVE AND CLINICAL UROLOGY, 2022, 63 (05) : 539 - 545
  • [44] Intravesical bacillus Calmette-Guerin versus chemohyperthermia for high-risk non-muscle-invasive bladder cancer
    Ekin, Rahmi Gokhan
    Akarken, Ilker
    Zorlu, Ferruh
    Tarhan, Huseyin
    Kucuk, Ulku
    Yildirim, Zubeyde
    Divrik, Rauf Taner
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2015, 9 (5-6): : E278 - E283
  • [45] Bacillus Calmette-Guerin Without Maintenance Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer
    Herr, Harry W.
    Dalbagni, Guido
    Donat, Sherri M.
    EUROPEAN UROLOGY, 2011, 60 (01) : 32 - 36
  • [46] Pyuria predicts poor prognosis in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin
    Azuma, Takeshi
    Nagase, Yasushi
    Oshi, Masaya
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (05) : 1113 - 1116
  • [47] Bacillus Calmette-Guerin unresponsiveness in non-muscle-invasive bladder cancer patients: what the urologists should know
    Moschini, Marco
    Zamboni, Stefania
    Mattei, Agostino
    Amparore, Daniele
    Fiori, Cristian
    De Dominicis, Carlo
    Esperto, Francesco
    MINERVA UROLOGICA E NEFROLOGICA, 2019, 71 (01) : 17 - 30
  • [48] Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guerin Immunotherapy
    Bacon, Jack V. W.
    Muller, David C.
    Ritch, Elie
    Annala, Matti
    Dugas, Sarah G.
    Herberts, Cameron
    Vandekerkhove, Gillian
    Seifert, Helge
    Zellweger, Tobias
    Black, Peter C.
    Bubendorf, Lukas
    Wyatt, Alexander W.
    Rentsch, Cyrill A.
    EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (06): : 677 - 686
  • [49] Salvage Therapies for Non-muscle-invasive Bladder Cancer: Who Will Respond to Bacillus Calmette-Guerin? Predictors and Nomograms
    Faba, Oscar Rodriguez
    Pisano, Francesca
    Krajewski, Wojciech
    Breda, Alberto
    Palou, Joan
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (01) : 5 - 13
  • [50] Efficacy and toxicity of intravesical Bacillus Calmette-Guerin therapy in elderly patients with non-muscle-invasive bladder cancer
    Matsuoka, Yuki
    Taoka, Rikiya
    Kohashiguchi, Kana
    Tohi, Yoichiro
    Miyauchi, Yasuyuki
    Kato, Takuma
    Tsunemori, Hiroyuki
    Ueda, Nobufumi
    Sugimoto, Mikio
    CURRENT UROLOGY, 2021, 15 (01) : 16 - 21